Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 401–404 of 404 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04746209	Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT	recruiting	Phase 2	25	Medical College of WisconsinOTHER	1	Sep 17, 2021	clinicaltrials
NCT03709719	Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia(GRAALL-QUEST)	active not recruiting	Phase 2	95	Assistance Publique - Hôpitaux de ParisOTHER	1	May 3, 2021	clinicaltrials